% | $
Quotes you view appear here for quick access.

Amicus Therapeutics, Inc. Message Board

SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    The States In which "The 12" are located

    by rjzamski Oct 18, 2015 1:27 PM

    The Pomerantz Law Firm
    600 Third Avenue
    NY NY 10016

  • Reply to

    Where To Complain

    by rjzamski Oct 18, 2015 12:24 PM

    It's quite likely there will be no loss by the time anything (if anything) went to court. Unless people sold low, this stock will come roaring back and exceed the price from which it fell.

    Sentiment: Strong Buy

  • I have other things to do today, but I began tracking down the addresses of "the 12". Guess what? So far they are all in New York City within a few blocks of each other. Hmm. Could they all belong to the same dining club?

    Howrd Feffer LLP 488 Madison Avenue, NY, NY.
    Brower Piven, PC 475 Park Avenue South, NY NY.
    The Pomerantz Firm, NYC
    Wolf Halderstein Alder NYC

    I'll post the addresses of the last two separately.

  • Reply to


    by equity_operations Oct 9, 2015 1:16 PM

    Yeah tell those stinky fingered guys to stay out of this.

  • This is now October 18th. Where's the class action suit. Ron

  • Reply to

    Fold - Fair Price

    by jc195573 Oct 16, 2015 1:34 PM

    Not so. It's $21.

  • Hey, Billy Bob good try. Take a look at my post "Ron Zamski Launces An Investigaton" You are providing good reference points. Incidentally, if I start a class action against the "12" , I will have our attorneys subpoena the telephone records of "The 12" and known short sellers. Better start looking at your phone calls Billy Bob.

  • From time to time I will be posting the addresses of the various State Attorneys General of the law firms involved in this herd filing law suit matter. I will also post the addresses and where possible the specific complaint personnel at affected state bar associations.

    I have had one question raised by a friend to my post. "Can the 12 law firms be sued for the losses incurred by FOLD shareholders." I am not an attorney, but it would seem that the measure of the loss would be the difference between the price of FOLD's stock on the date of the law firm's press release and the price of the stock today. This would be a matter to discuss with your attorney who obviously should not be one of the twelve affected law firms.

  • I am announcing on this Message Board an investigation into 12 law firms (named below) who apparently have filed spurious law suits against Amicus Therapeutics causing severe financial looses to its shareholders.

    I suspect that few or none of these firms represent clients who own or have owned Amicus Therapeutics stock (stock symbol FOLD.) I suspect that any alleged law suits filed did not have any named clients in the filings and were filed as "Plaintiffs to be named later" or some similar such designation. I suspect that these filings are loosely coordinated. I suspect that no moneys were spent on these so called "investigations." Twelve law firms apparently investigating a obscure press release by a small company on a mundane matter defies all sense of credibility.

    Investors in FOLD who have knowledge of these matters are encouraged to post information on the below named law firms activities to this Message Board for eventual forwarding to the Attorney Generals of their respective States and to professional associations that regulate attorneys in their respective states, such as bar associations. Let's put as end to this nonsense.

    The law firms are:

    Pomerantz Law Firm in New York
    Harwood Feffer LLP
    Brower Piven
    Wolf Haldenstein Alder Freeman & Herz LLP
    Ryan & Maniskas LLP
    Vincent Wong Notify
    Khang & Khang
    Willie Briscoe and Powers Taylor
    Robbin Arroyo LLP
    Levi & Korsinsky LLP
    Goldberg Law PC
    Wolf Popper LLP

    Ronald J. Zamski, retired CPA in New York & New Jersey, retired Senior Vice President & Director of the second largest bank in the world, graduate MBA in Taxation, manager/director of three different securities firms.

  • Reply to

    More potential lawsuits for FOLD

    by soriya999 Oct 10, 2015 2:32 PM

    Another firm looking for clients. Filing a law suit, or announcing an investigation, costs nothing or next to nothing. These actions are a way of soliciting new clients for these modern day ambulance chasers. Nothing more. In almost all cases these firms have no clients. Announcing an investigation costs absolutely nothing. They issue a press release thru an established website. No or very little cost. The press release gets posted here. Or they file a law suit - about $300 bucks, with unnamed claimants to be named later. A small cost. This is just advertising for the law firms. "Want to sue Amicus, call me. I have been working on this. I'm good! Call me."

    The really bad part is that some of them are hooked up with short sellers. They rely on inexperienced investors selling out in a panic. Don't panic. And don't listen to billy _bob, a guy with an apparently big short position. Ron

  • Reply to

    the evidence stacks up

    by billy_bob_jr_iii Oct 15, 2015 10:57 AM

    Aint no way this will bear the fruit of guilt and the stock will rally once again after European approval and in a few years, barring a market meltdown or a hillary clinton like strangle hold on drug pricing, the stock will be well over 20 bucks.

    With all due respect, I have seen these many times in biotech. It's part of owning the sector and if you don't understand it, you should probably not be in it. It's the riskiest sector in the world but too many think that these things do nothing but end up being winners. BIG BIG BIG risk with BIG reward but most fail.

  • All of these firms are vulture firms. I know this from other bio tech stocks that I have followed over the years. They have no clients. Nobody is complaining except them. They file a law suit with no clients and hope somebody will call up and become a client. There are a lot of these guys, 7 or 8 firms. Also several of them are hooked up with short sellers. They are simply "noise" to be ignored. Ron.

  • Reply to

    the evidence stacks up

    by billy_bob_jr_iii Oct 15, 2015 10:57 AM

    This is serious stuff billy-bob. Is there any way of finding out whether these sales were automatic, ordained in advance. If they were not, ......

  • Reply to

    Serious question to the true fold investors?

    by gmprv9345 Oct 9, 2015 8:56 PM

    You obviously have not gone through the results of the trials and even did not bother to understand the few sentences I wrote...I wrote I would not care if this agent would make me sh%T LESS or not...that is not the same as " will sh#t more"..
    "will sh^t more" implies that the agent actually causes or increases the frequency of bowel movements which the trials have clearly shown is not the case..
    finally, if the agent in fact did slightly increase GI discomfort or diarrhea, I would still be willing to take it given the enormous long term benefits on my vital organs...I see patients all the time tough out minor or even extremely dangerous side effects for major benefits. I am sure you have heard of something called chemotherapy or anticoagulants..
    ONE MORE THING: " will sh^t more" could actually be put on the label very simply if needed and if that were an adverse effect of the drug...have you ever seen the label of any drug..the side effects such as " may make you sleepy", " may cause diarrhea", "may impact your ability to make decisions" etc are part of drug labels all the time..
    I would recommend you discuss the evidence with a well qualified epidemiologist with a background in statistics as well as a cardiologist and a nephrologist who can explain to you what proteinuria reduction, LV mass reduction and slowing of GFR decline actually implies That will help you see the light imo

  • leading into surprise news over the weekend leading into a nice pop on Monday!

    In a perfect world.....

    Sentiment: Strong Buy

  • Reply to

    Looks like a quick rebound

    by gizmondo123 Oct 9, 2015 8:33 PM

    Was also thinking late November early December...

  • SHAREHOLDER ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Amicus Therapeutics, Inc. and Encourages Investors to Contact the FirmBusiness Wire(Wed, Oct 14)
    Amicus Therapeutics, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and DirectorsBusiness Wire(Wed, Oct 14)
    SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Amicus Therapeutics, Inc. and Certain Officers - FOLDPR Newswire(Tue, Oct 13)
    Robbins Arroyo LLP: Amicus Therapeutics, Inc. (FOLD) Misled Shareholders According to a Recently Filed Class ActionPR Newswire(Mon, Oct 12)
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Amicus Therapeutics, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of December 7, 2015 -- FOLDMarketwired(Mon, Oct 12)
    IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Amicus Therapeutics, Inc. and Encourages Shareholders to Contact the FirmBusiness Wire(Mon, Oct 12)
    Big Insider Buying Continues in Sprint, Lands’ End, Sears and Moreat 24/7 Wall St.(Sat, Oct 10)
    GPM Announces Investigation of Amicus Therapeutics, Inc.Business Wire(Fri, Oct 9)
    SHAREHOLDER NOTICE: Khang & Khang LLP Announces an Investigation of Claims Against Amicus Therapeutics, Inc. on Behalf of InvestorsBusiness Wire(Fri, Oct 9)
    Harwood Feffer LLP Announces Investigation of Amicus Therapeutics, Inc.PR Newswire(Fri, Oct 9)
    SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Amicus Therapeutics, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit -- FOLDGlobeNewswire(Fri, Oct 9)
    SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Amicus Therapeutics, Inc. and Certain Officers – FOLDGlobeNewswire(Fri, Oct 9)
    Kirby McInerney LLP Advises Amicus Therapeutics, In

  • Hope these were automatic annual sales of stock....otherwise the lawers are gonna have fun...

    Jul 16, 2015 CROWLEY JOHN F
    16,025 Direct Automatic Sale at $16 per share. 256,400
    Jul 16, 2015 CROWLEY JOHN F
    16,025 Direct Option Exercise at $16 per share. 256,400
    Jul 14, 2015 CROWLEY JOHN F
    142,250 Direct Automatic Sale at $15.03 per share. 2,138,017
    Jul 14, 2015 CROWLEY JOHN F
    142,250 Direct Option Exercise at $15.03 per share. 2,138,017
    Jul 13, 2015 CROWLEY JOHN F
    7,750 Direct Automatic Sale at $15.01 per share. 116,327
    Jul 13, 2015 CROWLEY JOHN F
    7,750 Direct Option Exercise at $15.01 per share. 116,327

  • Reply to

    Looks like a quick rebound

    by gizmondo123 Oct 9, 2015 8:33 PM

    Please explain why you feel this way?

    I see a company with a great pipeline, a recent excellent acquisition, and an experienced CEO dealing with the bureaucratic nightmare called the FDA.

    A huge market over reaction in my opinion. But then again I'm quite certain those who sold were VERY up already after buying in the 3s and 4s like I am.

    Based on your post with no thoughts to back it up the only thing I can assume is that you have a SHORT position and need the stock to go further lower to help make you money.

    These are just my opinions....and for the record I'm long and bought on this huge dip.

    So obviously I'm just as internally biased probably in wanting this stock to go up as you are wanting it to go down...

Must Watch
11.19+0.46(+4.29%)Nov 24 4:00 PMEST